BIENAIME JEAN JACQUES

BMRN

BIENAIME JEAN JACQUES serves as director at BioMarin Pharmaceutical Inc. (BMRN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

11 trades

$685.9K

Total Sells

42 trades

$77.84M

Net Position

Net Seller

$77.16M

Companies Traded

IMNM, KROS, BMRN

Active Period

Feb 2021 – Jun 2026

53 total trades

Most Recent

Buy IMNM

Jun 9, 2026 · $204.3K

BIENAIME JEAN JACQUES's Insider Trading at BioMarin Pharmaceutical Inc. (BMRN)

Buys

0 · $0.00

Sells

3 · $3.94M

Total Shares Bought

Total Shares Sold

50,085

BMRN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Mar 15, 2021	Sell	28,985	$78.16	$2.27M
Mar 4, 2021	Sell	14,100	$77.39	$1.09M
Feb 19, 2021	Sell	7,000	$83.58	$585.1K

Showing 51–53 of 53

Related Insiders

Julius Knowles

director

KROSSell · Jun 8, 2026

Nima Farzan

director

KROSSell · Jun 8, 2026

Seth Alpna

director

KROSSell · Jun 5, 2026

Gregory R Friberg

officer: EVP, Chief R&D Officer

BMRNSell · May 11, 2026

Max Rosett

officer: Chief Financial Officer

IMNMSell · Apr 3, 2026

Jack Higgins

officer: Chief Scientific Officer

IMNMSell · Apr 3, 2026

SIEGALL CLAY B

President and CEO

IMNMBuy · Mar 31, 2026

WAGENHEIM PHILIP

director

IMNMSell · Mar 23, 2026

Explore More Insider Trading Data

BMRN Insider Trading Activity

View all insider trades at BioMarin Pharmaceutical Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity